NDC properties for "benzocaine 20 % / lidocaine 4 % / tetracaine 1 % Topical Cream" (RxCUI 2275621)
About this data
The tables show NDC propoerties for benzocaine 20 % / lidocaine 4 % / tetracaine 1 % Topical Cream with the RxCUI 2275621
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for benzocaine 20 % / lidocaine 4 % / tetracaine 1 % Topical Cream (RxCUI 2275621)
| RxCUI | 2275621 |
|---|---|
| SPL_SET_ID | 9dc5db9d-9e0a-cd28-e053-2995a90a6bf7 |
| Prescribable Synonym | benzocaine 20 % / lidocaine 4 % / tetracaine 1 % Topical Cream |
| RXNAV_STR | benzocaine 200 MG/ML / lidocaine 40 MG/ML / tetracaine 10 MG/ML Topical Cream |
| RxNorm Name | benzocaine 200 MG/ML / lidocaine 40 MG/ML / tetracaine 10 MG/ML Topical Cream |
| RxNorm Synonym | benzocaine 20 % / lidocaine 4 % / tetracaine 1 % Topical Cream |
| Related queries | Interactions (for RxCUI 2275621) |
NDC Properties
NDC Item 73341000101
| NDC 9 | 73341-001 |
|---|---|
| NDC 10 | 73341-001-01 |
| NDC Item | 73341000101 |
| Packaging | 454 g in 1 JAR (73341-001-01) |
| FDA SPL set id | 820161 |
| Labeler | M2B Pharma LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-02-04 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 73341-001 |
NDC Item 73341000130
| NDC 9 | 73341-001 |
|---|---|
| NDC 10 | 73341-001-30 |
| NDC Item | 73341000130 |
| Packaging | 30 g in 1 JAR (73341-001-30) |
| FDA SPL set id | 820161 |
| Labeler | M2B Pharma LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-02-04 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 73341-001 |
NDC Item 73341000101
| NDC 9 | 73341-001 |
|---|---|
| NDC 10 | 73341-001-01 |
| NDC Item | 73341000101 |
| Packaging | 454 g in 1 JAR (73341-001-01) |
| FDA SPL set id | 820161 |
| Labeler | M2B Pharma LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-02-04 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 73341-001 |
NDC Item 73341000130
| NDC 9 | 73341-001 |
|---|---|
| NDC 10 | 73341-001-30 |
| NDC Item | 73341000130 |
| Packaging | 30 g in 1 JAR (73341-001-30) |
| FDA SPL set id | 820161 |
| Labeler | M2B Pharma LLC |
| Label type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Marketing effective time low | 2020-02-04 |
| Marketing status | ACTIVE |
| OTC_MONOGRAPH_DRUG | M017 |
| Related queries | Properties for NDC 9 73341-001 |